Expression of Fas/APO-1 and apoptosis of keratinocytes in human cholesteatoma

Laryngoscope

Volumn 109, Issue 4, 1999, Pages 613-616

  Park, Hong Joon ^a   Park, Keehyun ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Apoptosis; Cell death; Cholesteatoma; Fas APO 1

Indexed keywords

FAS ANTIGEN;

AGAR GEL ELECTROPHORESIS; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHOLESTEATOMA; CONTROLLED STUDY; DNA DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL;

EID: 0032917895     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199904000-00017     Document Type: Article

References (19)

1. Kojima H, Shiwa M, Kamide Y, Moriyama H. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol (Stockh) 1994;114:423-429.
2. Kojima H, Matsuhisa A, Shiwa M, Kamide Y, Nakmura M, Ohno T, Moriyama H. Expression of messenger RNA for keratinocyte growth factor in human cholesteatoma. Arch Otolaryngol Head Neck Surg 1996;122:157-160.
3. Bujia H, Holly A, Schilling V, Negri B, Pitzke P, Schulz P. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 1993;103:326-329.
4. Budtz PE, Spies I. Epidermal tissue homeostasis. Cell Tissue Res 1989;256:475-486.
5. McCall CA, Cohen JJ. Programmed cell death in terminally differentiating keratinocytes. J Invest Dermatol 1991;97: 111-114.
6. Shinoda H, Huang CC. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope 1995;105:1232-1237.
7. Lowe SW, Schmitt EM, Smith SW, Osborne BA, jacks T. p53 Is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993;362:847-849.
8. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169: 1747-1756.
9. Owen-Schaub LO, Zhang W, Cusac JC, et al. Wild-type-human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995;15:3030-3040.
10. Sayama K, Yonehara S, Watanabe Y, et al. Expression of Fas antigen on keratinocytes in vitro and induction of apoptosis in cultured keratinocytes. J Invest Dermatol 1994;103: 330-334.
11. Polakowska RR, Placentini M, Bartlett R, Goldsmith LA, Haake AR. Apoptosis in human skin development: morphogenesis periderm, and stem cells. Dev Dynamics 1994;199: 176-188.
12. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
13. Weedon D, Searle J, Kerr JFR. Apoptosis. Am J Dermatopathol 1993;1:133-144.
14. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
15. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-556.
16. Jacobson MD, Burne JF, King MP, Myyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993;361:365-368.
17. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell induced by c-myc is inhibited by bcl-2. Nature 1992;359:552-554.
18. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
19. Caelles C, Helmerg A, Karin M. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (London) 1994;370:220-223.